Nama Insights

Becton, Dickinson and Company (BDX)

Healthcare · Medical Instruments Supplies · NYSE

S&P 500
Becton, Dickinson and Company (BDX) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $49.85B, a trailing price-to-earnings ratio of 14.1 and a free-cash-flow yield of 5.1%. Over the most recent reported fiscal year, revenue grew 8.2% and free cash flow per share fell 12.3%.
Market cap$49.85B
Trailing P/E14.1
FCF yield5.1%
Revenue growth (YoY)+8.2%
EPS growth (YoY)+9.6%
FCF/share growth (YoY)-12.3%
ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments Supplies
Explore live BDX data on Nama Insights →

Recent Congressional trades

Becton, Dickinson and Company trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Thomas H. Kean House Sell $1,001 - $15,000 Jun 18, 2026
Kevin Hern House Sell $15,001 - $50,000 Apr 3, 2026
Lisa McClain House Sell $1,001 - $15,000 Aug 13, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Thomas H. Kean House Buy $1,001 - $15,000 Jun 17, 2025
Rob Bresnahan House Buy $1,001 - $15,000 Jun 9, 2025
Rob Bresnahan House Sell $1,001 - $15,000 Apr 28, 2025
Jefferson Shreve House Sell $15,001 - $50,000 Apr 11, 2025
John James House Sell $1,001 - $15,000 Sep 6, 2024
John James House Buy $1,001 - $15,000 Sep 2, 2024